Clinical Trials Directory

Trials / Completed

CompletedNCT06168253

Text Message Safety Behavior Fading for Social Anxiety

Text Message Safety Behavior Fading Intervention for Social Anxiety

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
201 (actual)
Sponsor
Florida State University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The current study aims to explore the efficacy of a text message based Safety Behavior Fading Intervention compared to an active control intervention.

Detailed description

Safety behavior fading may be a viable standalone intervention for social anxiety. In the present trial, participants high in social anxiety will be randomized to either receive a daily checklist exercise aimed at eliminating (1) safety behaviors or (2) unhealthy behaviors. Individuals randomly assigned to the safety behavior fading condition will receive instructions to decrease or eliminate their four most habitual social anxiety safety behaviors. In addition, they will receive daily reminders via text message to decrease these behaviors, along with a safety behavior monitoring checklist in which the participant indicates the extent to which they decreased and/or eliminated each safety behavior over the previous day. Individuals randomly assigned to the control condition will receive similar text messages and a daily checklist to encourage fading of unhealthy behaviors. Participants in both conditions will complete checklists for 28 days. After day 14 of treatment, participants will re-select their target safety behaviors or unhealthy behaviors, and will then be prompted to reduce these new behaviors for another 14 days.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSafety Behavior Fading for Social AnxietyParticipants are asked to reduce or eliminate safety behaviors via text message reminders and checklists to monitor progress.
BEHAVIORALUnhealthy Behavior FadingParticipants are asked to reduce or eliminate unhealthy behaviors via text message reminders and checklists to monitor progress.

Timeline

Start date
2024-01-01
Primary completion
2024-09-01
Completion
2024-09-01
First posted
2023-12-13
Last updated
2025-02-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06168253. Inclusion in this directory is not an endorsement.